Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 21:05:05 - browse：1971

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： How to fix cancer clinical trials' diversity problem

hotspot

WSS

'Make People Better': The CRISPR babies story you probably don't know

Couple fighting to bring baby home from Mexico are finally reunited

Advances in CAR

Norman Reedus' Daryl Dixon

The 10 drugs up first for Medicare price negotiation

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

focus

Wikipedia

focus

23andMe had bad news about my health. I wish a person had delivered it

Trump surgeon general acknowledges mistakes during Covid

Walensky prepares to leave CDC — and Congress — behind

Seattle police shoot person suspected in downtown stabbing

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How generative AI is inspiring dreams of a health data revolution

What does generative AI mean for health care? We asked experts

NIH nominee Bertagnolli will get October confirmation hearing

How to save PrEP access — and even expand it

Illumina names Agilent executive as new CEO

focus

ALS advocates say criticism of new drugs misses bigger picture

Stem cell treatment guidelines are released by FDA

Lindsay Lohan welcomes 1st child with husband Bader Shammas

AstraZeneca chief proposes a novel edit to the drug pricing bill

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Why the Crimean Bridge is key to Russia's war in Ukraine

hotspot

explore

entertainment

hotspot